- Home
- PCB vs ENGN Comparison
PCB vs ENGN Comparison
Compare PCB & ENGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PCB
- ENGN
- Stock Information
- Founded
- PCB 2003
- ENGN 1999
- Country
- PCB United States
- ENGN Canada
- Employees
- PCB 259
- ENGN N/A
- Industry
- PCB Major Banks
- ENGN
- Sector
- PCB Finance
- ENGN
- Exchange
- PCB Nasdaq
- ENGN Nasdaq
- Market Cap
- PCB 287.2M
- ENGN 297.7M
- IPO Year
- PCB N/A
- ENGN N/A
- Fundamental
- Price
- PCB $20.37
- ENGN $2.88
- Analyst Decision
- PCB Hold
- ENGN Buy
- Analyst Count
- PCB 2
- ENGN 7
- Target Price
- PCB $22.00
- ENGN $23.29
- AVG Volume (30 Days)
- PCB 40.4K
- ENGN 49.7K
- Earning Date
- PCB 04-24-2025
- ENGN 06-13-2025
- Dividend Yield
- PCB 4.02%
- ENGN N/A
- EPS Growth
- PCB 11.00
- ENGN N/A
- EPS
- PCB 1.94
- ENGN N/A
- Revenue
- PCB $98,720,000.00
- ENGN N/A
- Revenue This Year
- PCB $16.13
- ENGN N/A
- Revenue Next Year
- PCB $10.77
- ENGN N/A
- P/E Ratio
- PCB $10.27
- ENGN N/A
- Revenue Growth
- PCB 5.07
- ENGN N/A
- 52 Week Low
- PCB $14.50
- ENGN $3.27
- 52 Week High
- PCB $22.20
- ENGN $14.67
- Technical
- Relative Strength Index (RSI)
- PCB 66.42
- ENGN 19.55
- Support Level
- PCB $19.66
- ENGN $3.51
- Resistance Level
- PCB $20.34
- ENGN $3.99
- Average True Range (ATR)
- PCB 0.54
- ENGN 0.43
- MACD
- PCB 0.12
- ENGN -0.07
- Stochastic Oscillator
- PCB 99.46
- ENGN 0.00
About PCB PCB Bancorp
PCB Bancorp is a bank holding company, which engages in the provision of consumer and commercial banking services. It provides Personal, Business, and Loan services, which provide banking, lending, and digital, tools, home loans, and others. Also, it offers a broad range of loans, deposits, and other products and services predominantly to small and middle-market businesses and individuals. The company provided it's services in Los Angeles and Orange Counties, California; Bellevue, Washington; and Atlanta, Georgia.
About ENGN enGene Holdings Inc.
enGene Holdings Inc is a clinical-stage biotechnology company focused on developing gene therapies to improve the lives of patients. The Company is developing non-viral gene therapies based on its novel and proprietary dually derived chitosan, or DDX, gene delivery platform, which allows localized delivery of multiple gene cargos directly to mucosal tissues and other organs.